Modelling the protective efficacy of alternative delivery schedules for intermittent preventive treatment of malaria in infants and children

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Cairns, Matthew ^a   Ghani, Azra ^b   Okell, Lucy ^b   Gosling, Roly ^a   Carneiro, Ilona ^a   Anto, Francis ^c   Asoala, Victor ^c   Owusu Agyei, Seth ^d   Greenwood, Brian ^a   Chandramohan, Daniel ^a   Milligan, Paul ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c NAVRONGO HEALTH RESEARCH CENTRE   (Ghana)

^d KINTAMPO HEALTH RESEARCH CENTRE   (Ghana)

Author keywords

[No Author keywords available]

Indexed keywords

ARTEMISININ; CHLOROQUINE; LONG ACTING DRUG; PLACEBO; PYRIMETHAMINE PLUS SULFADOXINE; ANTIMALARIAL AGENT; PYRIMETHAMINE; SULFADOXINE; SULFADOXINE-PYRIMETHAMINE;

ARTICLE; CASE MANAGEMENT; CHILD; CHILD CARE; CONTROLLED STUDY; DOSAGE SCHEDULE COMPARISON; DOSE TIME EFFECT RELATION; DRUG EFFICACY; DRUG INTERMITTENT THERAPY; GHANA; HUMAN; IMMUNIZATION; INCIDENCE; INFANT; MALARIA; MALARIA CONTROL; PREDICTION; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SEASONAL VARIATION; VACCINATION; DRUG COMBINATION; SEASON; THEORETICAL MODEL; VALIDATION STUDY;

ANTIMALARIALS; CHILD, PRESCHOOL; DRUG COMBINATIONS; HUMANS; INFANT; MALARIA; MODELS, THEORETICAL; PYRIMETHAMINE; SEASONS; SULFADOXINE;

EID: 79955367749     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0018947     Document Type: Article

References (52)

1. Aponte JJ, Schellenberg D, Egan A, Breckenridge A, Carneiro I, et al. (2009) Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trials. Lancet 374: 1533-1542.
2. Pool R, Mushi A, Schellenberg JA, Mrisho M, Alonso P, et al. (2008) The acceptability of intermittent preventive treatment of malaria in infants (IPTi) delivered through the expanded programme of immunization in southern Tanzania. Malar J 7: 213.
3. Hutton G, Schellenberg D, Tediosi F, Macete E, Kahigwa E, et al. (2009) Cost-effectiveness of malaria intermittent preventive treatment in infants (IPTi) in Mozambique and the United Republic of Tanzania. Bull World Health Organ 87: 123-129.
4. Conteh L, Sicuri E, Manzi F, Hutton G, Obonyo B, et al. (2010) The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan Africa. PLoS One 5: e10313.
5. World Health Organisation (2009) Report of the Technical Consultation on Intermittent Preventive Treatment in Infants (IPTi), Technical Expert Group on Preventive Chemotherapy, 23-24 April 2009- WHO\HQ, Geneva, Switzerland.
6. Cisse B, Sokhna C, Boulanger D, Milet J, Ba EH, et al. (2006) Seasonal intermittent preventive treatment with artesunate and sulfadoxine-pyrimethamine for prevention of malaria in Senegalese children: a randomised, placebo-controlled, double-blind trial. Lancet 367: 659-667.
7. Dicko A, Sagara I, Sissoko MS, Guindo O, Diallo AI, et al. (2008) Impact of intermittent preventive treatment with sulphadoxine-pyrimethamine targeting the transmission season on the incidence of clinical malaria in children in Mali. Malar J 7: 123.
8. Kweku M, Liu D, Adjuik M, Binka F, Seidu M, et al. (2008) Seasonal intermittent preventive treatment for the prevention of anaemia and malaria in ghanaian children: a randomized, placebo controlled trial. PLoS ONE 3: e4000.
9. Sokhna C, Cisse B, Ba EH, Milligan P, Hallett R, et al. (2008) A Trial of the Efficacy, Safety and Impact on Drug Resistance of Four Drug Regimens for Seasonal Intermittent Preventive Treatment for Malaria in Senegalese Children. PLoS ONE 3: e1471.
10. Cairns M, Carneiro I, Milligan P, Owusu-Agyei S, Awine T, et al. (2008) Duration of Protection against Malaria and Anaemia Provided by Intermittent Preventive Treatment in Infants in Navrongo, Ghana. PLoS ONE 3: e2227.
11. May J, Adjei S, Busch W, Gabor JJ, Issifou S, et al. (2008) Therapeutic and prophylactic effect of intermittent preventive anti-malarial treatment in infants (IPTi) from Ghana and Gabon. Malar J 7: 198.
12. Cairns ME, Gosling RD, Carneiro I, Gesase S, Mosha JF, et al. (2010) Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS ONE 5: e9467.
13. Smith DL, Dushoff J, Snow RW, Hay SI, (2005) The entomological inoculation rate and Plasmodium falciparum infection in African children. Nature 438: 492-495.
14. Carneiro I, Roca-Feltrer A, Griffin JT, Smith L, Tanner M, et al. (2010) Age-patterns of malaria vary with severity, transmission intensity and seasonality in sub-Saharan Africa: a systematic review and pooled analysis. PLoS One 5: e8988.
15. Ceesay SJ, Casals-Pascual C, Erskine J, Anya SE, Duah NO, et al. (2008) Changes in malaria indices between 1999 and 2007 in The Gambia: a retrospective analysis. Lancet 372: 1545-1554.
16. Guerra CA, Gikandi PW, Tatem AJ, Noor AM, Smith DL, et al. (2008) The limits and intensity of Plasmodium falciparum transmission: implications for malaria control and elimination worldwide. PLoS Med 5: e38.
17. O'Meara WP, Bejon P, Mwangi TW, Okiro EA, Peshu N, et al. (2008) Effect of a fall in malaria transmission on morbidity and mortality in Kilifi, Kenya. Lancet 372: 1555-1562.
18. Schellenberg D, Menendez C, Aponte JJ, Kahigwa E, Tanner M, et al. (2005) Intermittent preventive antimalarial treatment for Tanzanian infants: follow-up to age 2 years of a randomised, placebo-controlled trial. Lancet 365: 1481-1483.
19. Mwangi TW, Fegan G, Williams TN, Kinyanjui SM, Snow RW, et al. (2008) Evidence for over-dispersion in the distribution of clinical malaria episodes in children. PLoS ONE 3: e2196.
20. White NJ, (2008) How antimalarial drug resistance affects post treatment prophylaxis. Malar J 7: 9.
21. Nosten F, van Vugt M, Price R, Luxemburger C, Thway KL, et al. (2000) Effects of artesunate-mefloquine combination on incidence of Plasmodium falciparum malaria and mefloquine resistance in western Thailand: a prospective study. Lancet 356: 297-302.
22. Bhattarai A, Ali AS, Kachur SP, Martensson A, Abbas AK, et al. (2007) Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar. PLoS Med 4: e309.
23. Robert V, Dieng H, Lochouran L, Traore SF, Trape JF, et al. (1998) [Malaria transmission in the rural zone of Niakhar, Senegal]. Trop Med Int Health 3: 667-677.
24. Chandramohan D, Owusu-Agyei S, Carneiro I, Awine T, Amponsa-Achiano K, et al. (2005) Cluster randomised trial of intermittent preventive treatment for malaria in infants in area of high, seasonal transmission in Ghana. British Medical Journal 331: 727-733.
25. Anto F, Tindana C, Asoala V, Awini E, Adjuik M, et al. (2004) Entomological inoculation rate in Kassena Nankana District, Ghana: Nov 2001 to October 2004 (unpublished data).
26. Wearing HJ, Rohani P, Keeling MJ, (2005) Appropriate models for the management of infectious diseases. PLoS Med 2: e174.
27. Okell LC, Drakeley CJ, Bousema T, Whitty CJ, Ghani AC, (2008) Modelling the impact of artemisinin combination therapy and long-acting treatments on malaria transmission intensity. PLoS Med 5: e226; discussion e226.
28. Oduro AR, Anyorigiya T, Hodgson A, Ansah P, Anto F, et al. (2005) A randomized comparative study of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Ghana. Trop Med Int Health 10: 279-284.
29. Woolhouse ME, Dye C, Etard JF, Smith T, Charlwood JD, et al. (1997) Heterogeneities in the transmission of infectious agents: implications for the design of control programs. Proc Natl Acad Sci U S A 94: 338-342.
30. Baird JK, Owusu Agyei S, Utz GC, Koram K, Barcus MJ, et al. (2002) Seasonal malaria attack rates in infants and young children in northern Ghana. Am J Trop Med Hyg 66: 280-286.
31. Roca-Feltrer A, Armstrong Schellenberg JR, Smith L, Carneiro I, (2009) A simple method for defining malaria seasonality. Malar J 8: 276.
32. Bojang KA, Akor F, Conteh L, Webb E, Bittaye O, et al. (2011) Two Strategies for the Delivery of IPTc in an Area of Seasonal Malaria Transmission in The Gambia: A Randomised Controlled Trial. PLoS Med 8: e1000409.
33. Tagbor H, Cairns M, Nakwa E, Browne E, Sarkodie B, et al. (2010) The clinical impact of combining intermittent preventive treatment with home management of malaria in children aged below 5 years: cluster randomised trial. Trop Med Int Health.
34. Ahorlu CK, Koram K, Seakey A, Weiss M, (2009) Effectiveness of combined intermittent preventive treatment for children and timely home treatment for malaria control. Malaria Journal 8: 292.
35. Cisse B, Faye S, Dial Y, Faye O, Gaye O, et al. (2007) Pilot study of the implementation of seasonal intermittent preventive treatment in children (IPTc) with community participation in Senegal. European Congress of Tropical Medicine and International Health. Amsterdam.
36. Conteh L, Patouillard E, Kweku M, Legood R, Greenwood B, et al. (2010) Cost effectiveness of seasonal intermittent preventive treatment using amodiaquine & artesunate or sulphadoxine-pyrimethamine in Ghanaian children. PLoS One 5: e12223.
37. Greenwood BM, David PH, Otoo-Forbes LN, Allen SJ, Alonso PL, et al. (1995) Mortality and morbidity from malaria after stopping malaria chemoprophylaxis. Trans R Soc Trop Med Hyg 89: 629-633.
38. Cairns M, Gosling R, Carneiro I, Gesase S, Mosha JF, et al. (2010) Duration of protection against clinical malaria provided by three regimens of intermittent preventive treatment in Tanzanian infants. PLoS ONE 5: e9467.
39. Griffin JT, Cairns M, Ghani AC, Roper C, Schellenberg D, et al. (2010) Protective Efficacy of Intermittent Preventive Treatment of Malaria in Infants (IPTi) Using Sulfadoxine-Pyrimethamine and Parasite Resistance. PLoS One 5: e12618.
40. Alexander N, Sutherland C, Roper C, Cisse B, Schellenberg D, (2007) Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance. Malar J 6: 9.
41. Charlwood JD, Smith T, Lyimo E, Kitua AY, Masanja H, et al. (1998) Incidence of Plasmodium falciparum infection in infants in relation to exposure to sporozoite-infected anophelines. Am J Trop Med Hyg 59: 243-251.
42. Smith T, Maire N, Dietz K, Killeen GF, Vounatsou P, et al. (2006) RELATIONSHIP BETWEEN THE ENTOMOLOGIC INOCULATION RATE AND THE FORCE OF INFECTION FOR PLASMODIUM FALCIPARUM MALARIA. Am J Trop Med Hyg 75: 11-18.
43. Beier JC, Oster CN, Onyango FK, Bales JD, Sherwood JA, et al. (1994) Plasmodium falciparum incidence relative to entomologic inoculation rates at a site proposed for testing malaria vaccines in western Kenya. Am J Trop Med Hyg 50: 529-536.
44. Dietz K, Molineaux L, Thomas A, (1974) A malaria model tested in African savannah. Bulletin of the World Health Organisation 50: 347-357.
45. Sinden RE, Gilles HM, (2002) The malaria parasites. In: Warrell DA, Gilles HM, editors. Essential malariology. Fourth Edition ed London Arnold.
46. Epstein JE, Rao S, Williams F, Freilich D, Luke T, et al. (2007) Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update. J Infect Dis 196: 145-154.
47. Smith T, Felger I, Kitua A, Tanner M, Beck HP, (1999) Dynamics of multiple Plasmodium falciparum infections in infants in a highly endemic area of Tanzania. Trans R Soc Trop Med Hyg 93 (Suppl 1): 35-39.
48. Smith T, Felger I, Beck HP, Tanner M, (1999) Consequences of multiple infection with Plasmodium falciparum in an area of high endemicity. Parassitologia 41: 247-250.
49. Falk N, Maire N, Sama W, Owusu-Agyei S, Smith T, et al. (2006) Comparison of PCR-RFLP and Genescan-based genotyping for analyzing infection dynamics of Plasmodium falciparum. Am J Trop Med Hyg 74: 944-950.
50. Smith T, Vounatsou P, (2003) Estimation of infection and recovery rates for highly polymorphic parasites when detectability is imperfect, using hidden Markov models. Stat Med 22: 1709-1724.
51. Bejon P, Warimwe G, Mackintosh CL, Mackinnon MJ, Kinyanjui SM, et al. (2009) Analysis of immunity to febrile malaria in children that distinguishes immunity from lack of exposure. Infect Immun 77: 1917-1923.
52. Watkins WM, Mberu EK, Winstanley PA, Plowe CV, (1997) The efficacy of antifolate antimalarial combinations in Africa: a predictive model based on pharmacodynamic and pharmacokinetic analyses. Parasitol Today 13: 459-464.